Back to results
US 2003/0204076 A1Published application
Antisense modulation of vascular endothelial growth factor receptor-1 expression
OwnerC. Frank Bennett, Andrew T. Wattinventors
Life of this patent
Estimating the term…
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of vascular endothelial growth factor receptor-1. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding vascular endothelial growth factor receptor-1. Methods of using these compounds for modulation of vascular endothelial growth factor receptor-1 expression and for treatment of diseases associated with expression of vascular endothelial growth factor receptor-1 are provided.
Claims13
An antisense compound consisting of SEQ ID NO:
- 22, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 44, 45, 46, 48, 49, 50, 51, 52, 53, 54, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 67, 68, 70, 71, 72, 73, 74, 75, 76, 78, 79, 81, 83, 87, 88, 90, 91, 92, 93, 95, 96, 97, 98, 99, 69, 82, 85, 102, 103, 104, 105, 107, 108, 109, 111, 113, 114, 115, 116, 119, 120, 121, 122, 124, 125, 126, 127, 128, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 149, 150, 151, 152, 153 or 154 which inhibits the expression of vascular endothelial growth factor receptor-1.
Dependencies are inferred from the claim text.